Form 4: Labcorp EVP Exercises RSUs, Sells Shares for Tax

Labcorp's EVP of Corporate Affairs, Sandra D. van der Vaart, reported the vesting and exercise of Restricted Stock Units and subsequent sale of shares to cover tax obligations.

Summary

• Sandra D. van der Vaart, EVP, Corporate Affairs at Labcorp Holdings Inc., reported transactions on February 11, 2026.
• 376 Restricted Stock Units (RSUs) vested and were converted into common stock.
• Following the vesting, 99 shares of common stock were sold at $289.89 per share to satisfy tax withholding obligations.
• After these transactions, van der Vaart directly owns 3,126.4864 shares of common stock.
• She also holds 1,141 unvested Restricted Stock Units.
• The vested RSUs were part of a grant that vests in three equal annual installments, with the first installment occurring on February 11, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting a routine compensation action for an executive, which aligns their interests with shareholders through equity ownership, despite a small tax-related sale.

Positives

• The executive's continued holding of 3,126.4864 common shares and 1,141 unvested RSUs indicates ongoing alignment with shareholder interests.
• The vesting of RSUs represents a planned compensation event for the executive.

Negatives

• The sale of 99 shares, while for tax purposes, reduces the executive's direct common stock holdings.

Future Outlook

The filing indicates that the remaining 1,141 Restricted Stock Units will vest in two additional equal annual installments following the initial vesting on February 11, 2026.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and subsequent tax-related sales, are common occurrences in executive compensation structures across various industries, including the healthcare diagnostics sector where Labcorp operates. These transactions typically reflect pre-scheduled compensation events rather than discretionary trading based on new material information.

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and ownership, which can be viewed as a positive signal of alignment, though the tax-related sale slightly reduces direct holdings.
• Executive (Sandra D. van der Vaart): Realizes value from vested equity compensation, while maintaining significant equity exposure to the company.

Next Steps

• Remaining Restricted Stock Units will vest in two additional equal annual installments after February 11, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations. Such transactions are typically pre-scheduled and do not inherently signal a change in the company's fundamental outlook or the executive's confidence. While the executive sold a small portion of shares, it was for tax purposes, and a substantial number of shares and RSUs are still held, indicating continued alignment. Therefore, based solely on this filing, a seasoned investor would likely maintain their current position, as it provides no new material information to warrant a change in investment strategy.

Keywords

Labcorp Holdings Inc., LH, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Sandra D. van der Vaart, Stock Sale, Tax Withholding